| __timestamp | Alkermes plc | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 19586000 |
| Thursday, January 1, 2015 | 4019000 | 29135000 |
| Friday, January 1, 2016 | 2301000 | 42791000 |
| Sunday, January 1, 2017 | 7232000 | 49577000 |
| Monday, January 1, 2018 | 68895000 | 89209000 |
| Tuesday, January 1, 2019 | 52816000 | 69099000 |
| Wednesday, January 1, 2020 | 1946000 | 75961000 |
| Friday, January 1, 2021 | 1020000 | 90467000 |
| Saturday, January 1, 2022 | 393842000 | 74552000 |
| Sunday, January 1, 2023 | 270806000 | 91593000 |
| Monday, January 1, 2024 | 245326000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Alkermes plc and Supernus Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Alkermes plc's R&D expenses surged dramatically, peaking in 2022 with a staggering 3,938% increase compared to 2014. This reflects a strategic pivot towards aggressive innovation. In contrast, Supernus Pharmaceuticals, Inc. maintained a more consistent R&D expenditure, with a notable 367% increase over the same period, highlighting a steady commitment to research.
These trends underscore the differing approaches: Alkermes' bold investment strategy versus Supernus' steady growth. As the pharmaceutical industry evolves, these R&D investments will likely play a pivotal role in shaping the future of both companies.
Eli Lilly and Company or Alkermes plc: Who Invests More in Innovation?
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for BeiGene, Ltd. and Alkermes plc
Research and Development Investment: Summit Therapeutics Inc. vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and Alkermes plc
Analyzing R&D Budgets: Lantheus Holdings, Inc. vs Alkermes plc
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.